Launch a PE-Backed Corporate Pain Management Group

1. 1

   Write the consolidation thesis

   The model buys fragmented, physician-owned pain practices and ASCs and creates value by centralizing overhead and buying at a lower multiple than the platform later sells at. Your thesis names the geography, the target practice profile, the ancillary revenue (ASCs, ancillaries, device volume), and the operating improvements you will make. This is a finance-plus-medicine plan, so it must convince capital partners and physician sellers at the same time. A weak thesis is why many roll-ups stall.

2. 2

   Secure capital and align physician incentives

   PE funds, family offices, or strategic acquirers provide the capital; the hard part is structuring physician rollover equity and compensation so acquired doctors stay productive after the sale. Roughly 70 percent of the field is already employed this way, so sellers are familiar with the model, but retention risk is the central operating risk. Align incentives so physicians share in the platform's growth, not just the initial check. Misaligned earnouts are a classic roll-up failure.

3. 3

   Structure a compliant management-services organization

   Because many states bar corporate ownership of medical practices (corporate-practice-of-medicine rules), the standard structure is a management-services organization (MSO) that owns the non-clinical assets and contracts with a physician-owned entity. Stark Law and the Anti-Kickback Statute also govern referrals to owned ASCs and ancillaries. This structuring is not optional and not generic, so it needs specialized health-care transactional counsel from the first deal. Get it wrong and the whole platform is exposed.

4. 4

   Acquire an anchor platform, then tuck-ins

   Roll-ups start with a larger anchor practice that sets the operating standard, then add smaller tuck-in practices and ASCs that plug into shared billing, purchasing, prior-auth, and compliance. Each tuck-in should be accretive: cheaper to buy than its contribution to platform value. Centralized functions (RCM, credentialing, DEA and controlled-substance compliance, device purchasing) are where the margin improvement actually comes from. Integration discipline, not deal volume, determines returns.

5. 5

   Operate for the exit

   The value event is usually a sale to a larger PE fund or strategic at a higher multiple than the tuck-ins were bought for, so the platform is built to be sold: clean financials, standardized operations, strong physician retention, and diversified payer and referral mix. Manage the regulatory file continuously (Stark, AKS, MSO compliance) because acquirers diligence it hard. The whole enterprise is a multi-year value-creation and exit exercise, not a steady-state operating business.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.